Antiidiotype antibody therapy of B-cell lymphoma.
Brown
S L
SL
Department of Medicine, Stanford University School of Medicine, CA 94305.
Miller
R A
RA
Levy
R
R
D000818:Animals; D000906:Antibodies / Q000008:administration & dosage* / Q000276:immunology; D000917:Antibody Formation; D000937:Antigen-Antibody Reactions; D001402:B-Lymphocytes / Q000276:immunology; D003429:Cross Reactions; D006801:Humans; D007116:Immunization, Passive; D007130:Immunoglobulin Idiotypes / Q000276:immunology*; D007167:Immunotherapy; D007370:Interferon Type I / Q000008:administration & dosage / Q000627:therapeutic use; D008223:Lymphoma / Q000097:blood / Q000276:immunology / Q000628:therapy*; D051379:Mice; D012074:Remission Induction
D000906:Antibodies; D007130:Immunoglobulin Idiotypes; D007370:Interferon Type I